Diligence memo · auto-generated · as of July 2, 2026
TetraScience, Inc.
TetraScience, Inc. has raised $66M over 2 rounds; too few niche peers to rank its valuation yet.
Businessfiled
TetraScience, Inc. operates in Biotech, based in Boston, MA, USA; Remote. The only R&D data cloud for life sciences
Sub-sector tags: Data Engineering, SaaS, biotech, data/analytics, pharma, saas.
Capital & rounds (filed)filed
TetraScience, Inc. has raised $66M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $51M on 2021-03-26.
Most recent recorded round closed around 2026-02-13.
Valuation (modeled)modeled
Provath models TetraScience, Inc. at approximately $72M (range $46M–$88M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 59 months.
Last raise 5 mo ago; this sector typically re-raises about every 11 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 3.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 99% of Biotech peers (233 compared).
Modeled value ranks above 85% of those peers.
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.